Julia M L Brotherton

Summary

Country: Australia

Publications

  1. pmc Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
    Suzanne M Garland
    Regional World Health Organisation Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
    BMC Med 9:104. 2011
  2. doi Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey
    Julia M L Brotherton
    National HPV Vaccination Program Register, VCS Inc, PO Box 310, East Melbourne 8002, Victoria, Australia Discipline of Paediatrics and Child Health, University of Sydney, Locked Bag 4001, Westmead 2145, New South Wales, Australia Melbourne School of Population and Global Health, 207 Bouverie Street, The University of Melbourne, Parkville, Victoria 2010, Australia Electronic address
    Vaccine 32:592-7. 2014
  3. ncbi Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach
    Julia M L Brotherton
    National HPV Vaccination Program Register, Victorian Cytology Service, Melbourne, Vic, Australia
    Med J Aust 199:614-7. 2013
  4. pmc Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)
    Elisa J Young
    Department of Microbiology and Infectious Diseases, Royal Women s Hospital, Parkville, Melbourne, VIC 3052, Australia
    BMC Cancer 13:296. 2013
  5. doi Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia
    Julia M L Brotherton
    Victorian Cytology Service, East Melbourne 8002, Victoria, Australia
    Cancer Epidemiol 36:298-302. 2012
  6. doi Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance
    Julia M L Brotherton
    Regional WHO Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
    Future Microbiol 7:193-9. 2012
  7. pmc Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods
    Bette Liu
    The Kirby Institute, University of New South Wales, Sydney, Australia
    BMC Med Res Methodol 11:159. 2011
  8. ncbi Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register
    Julia Brotherton
    National HPV Vaccination Program Register, East Melbourne, Victoria
    Commun Dis Intell Q Rep 35:197-201. 2011
  9. ncbi Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact
    Julia M L Brotherton
    National HPV Vaccination Program Register, Victorian Cytology Service Registries, Victorian Cytology Service, PO Box 310, East Melbourne, Victoria 8002, Australia
    Expert Rev Anti Infect Ther 9:627-39. 2011
  10. doi Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
    Julia M L Brotherton
    Victorian Cytology Service Registries, Victorian Cytology Service, East Melbourne, Vic, Australia
    Lancet 377:2085-92. 2011

Detail Information

Publications28

  1. pmc Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
    Suzanne M Garland
    Regional World Health Organisation Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
    BMC Med 9:104. 2011
    ..Prior to introduction of a national human papilloma virus (HPV) vaccination program, we determined HPV genotype prevalence by Indigenous status and residence in remote areas...
  2. doi Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey
    Julia M L Brotherton
    National HPV Vaccination Program Register, VCS Inc, PO Box 310, East Melbourne 8002, Victoria, Australia Discipline of Paediatrics and Child Health, University of Sydney, Locked Bag 4001, Westmead 2145, New South Wales, Australia Melbourne School of Population and Global Health, 207 Bouverie Street, The University of Melbourne, Parkville, Victoria 2010, Australia Electronic address
    Vaccine 32:592-7. 2014
    ..In 2011, we undertook a population-based mobile phone survey of young women to independently estimate HPV vaccination coverage...
  3. ncbi Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach
    Julia M L Brotherton
    National HPV Vaccination Program Register, Victorian Cytology Service, Melbourne, Vic, Australia
    Med J Aust 199:614-7. 2013
    ..To describe quadrivalent human papillomavirus (HPV) vaccination coverage achieved in the HPV vaccination catch-up program for girls aged 12-17 years...
  4. pmc Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)
    Elisa J Young
    Department of Microbiology and Infectious Diseases, Royal Women s Hospital, Parkville, Melbourne, VIC 3052, Australia
    BMC Cancer 13:296. 2013
    ..In sub study B, the distribution of human papillomavirus genotypes detected in high grade cervical intraepithelial neoplastic lesions from vaccine eligible women is being assessed...
  5. doi Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia
    Julia M L Brotherton
    Victorian Cytology Service, East Melbourne 8002, Victoria, Australia
    Cancer Epidemiol 36:298-302. 2012
    ..To assess human papillomavirus (HPV) vaccination coverage and attitudes to vaccination and Pap screening in young women...
  6. doi Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance
    Julia M L Brotherton
    Regional WHO Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
    Future Microbiol 7:193-9. 2012
    ....
  7. pmc Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods
    Bette Liu
    The Kirby Institute, University of New South Wales, Sydney, Australia
    BMC Med Res Methodol 11:159. 2011
    ..We therefore sought to examine the feasibility of recruiting young women for a national health survey through random digit dialling mobile phones...
  8. ncbi Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register
    Julia Brotherton
    National HPV Vaccination Program Register, East Melbourne, Victoria
    Commun Dis Intell Q Rep 35:197-201. 2011
    ..Some of the differences in the coverage observed between states and territories likely reflect differing mechanisms for notifying to the Register...
  9. ncbi Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact
    Julia M L Brotherton
    National HPV Vaccination Program Register, Victorian Cytology Service Registries, Victorian Cytology Service, PO Box 310, East Melbourne, Victoria 8002, Australia
    Expert Rev Anti Infect Ther 9:627-39. 2011
    ..This article considers the current issues and challenges in delivering primary HPV vaccination programs effectively and the likely impact of the vaccines in both the near and more distant future...
  10. doi Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
    Julia M L Brotherton
    Victorian Cytology Service Registries, Victorian Cytology Service, East Melbourne, Vic, Australia
    Lancet 377:2085-92. 2011
    ..We analysed trends in cervical abnormalities in women in Victoria, Australia, before and after introduction of the vaccination programme...
  11. ncbi Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia
    Julia M L Brotherton
    National Centre for Immunisation Research and Surveillance and University of Sydney, New South Wales
    Commun Dis Intell Q Rep 32:457-61. 2008
    ..Public sector immunisation providers across Australia should be commended for planning and implementing a new national immunisation program in approximately 4 months...
  12. doi Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy
    Julia M L Brotherton
    Victorian Cytology Service, East Melbourne, Australia
    Sex Health 7:310-9. 2010
    ..Australia is well placed to monitor the impact of its HPV vaccination program as well as to measure vaccine effectiveness with existing HPV vaccines, cervical screening and cancer registries...
  13. doi National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program
    Julia M L Brotherton
    Victorian Cytology Service, East Melbourne, Australia
    Sex Health 7:291-8. 2010
    ..We investigated GPs' experiences of delivering the HPV vaccine to women aged 18-26...
  14. ncbi The incidence of genital warts in Australian women prior to the national vaccination program
    Julia M L Brotherton
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, Westmead, NSW 2145, Australia
    Sex Health 6:178-84. 2009
    ..A surveillance system capable of documenting any decrease in the incidence of genital warts and recurrent respiratory papillomatosis after vaccination is urgently required...
  15. ncbi Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
    Dorota M Gertig
    VCS Inc, 265 Faraday St, Carlton, VIC 3053, Australia
    BMC Med 11:227. 2013
    ..We present data from the school-based program on population-level vaccine effectiveness against cervical abnormalities in Victoria, Australia...
  16. doi Fall in human papillomavirus prevalence following a national vaccination program
    Sepehr N Tabrizi
    Regional World Health Organization Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Victoria, Australia
    J Infect Dis 206:1645-51. 2012
    ..We evaluated the program's impact on genotype-specific HPV infection prevalence through a repeat survey of women attending clinical services...
  17. doi "I just signed": Factors influencing decision-making for school-based HPV vaccination of adolescent girls
    Spring Chenoa Cooper Robbins
    Discipline of Paediatrics and Child Health, University of Sydney, Australia, at The Children s Hospital at Westmead, Sydney, Australia
    Health Psychol 29:618-25. 2010
    ..To date, there are no published studies describing decision-making processes and behavior postimplementation of HPV vaccination of adolescents participating in a school-based program...
  18. doi Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention
    Suzanne M Garland
    Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Melbourne, Victoria, Australia
    Vaccine 26:M80-8. 2008
    ..This represents a successful model for other countries. We present data on cervical cancer, risk factors and prevention strategies, including epidemiology of HPV and HPV vaccine strategies...
  19. doi Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia
    Dorota M Gertig
    Victorian Cytology Service, PO Box 161, Carlton South, VIC 3053, Australia
    Sex Health 8:171-8. 2011
    ..Future monitoring of vaccine effectiveness will be facilitated by cross-linking to Pap test registries...
  20. ncbi HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program
    Sepehr N Tabrizi
    Regional WHO HPV Reference Laboratory, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Parkville, Victoria, Australia Murdoch Childrens Research Institute, Parkville, Victoria, Australia Department of Obstetrics and Gynaecology, University of Melbourne, Victoria, Australia Electronic address
    J Clin Virol 60:250-6. 2014
    ..Data on the prevalence of cervical HPV genotypes in Australia by age and by grade of cytological abnormality are sparse...
  21. doi Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia
    Farhana Sultana
    Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia
    BMC Cancer 14:207. 2014
    ..The iPap trial will evaluate whether mailing an HPV self-sampling kit increases participation by never- and under-screened women within a cervical screening program...
  22. doi Adolescent and young adult HPV vaccination in Australia: achievements and challenges
    Suzanne M Garland
    Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Parkville, Victoria, Australia
    Prev Med 53:S29-35. 2011
    ..Challenges for the future include how we can sustain and improve HPV vaccination coverage in young Australian women, while maintaining cervical cancer screening participation and reviewing cervical cancer screening methods...
  23. ncbi How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions
    Emma T Callegari
    The University of Melbourne, Grattan Street, Parkville, Melbourne 3010, Vic, Australia Murdoch Childrens Research Institute, Parkville, Vic, Australia Electronic address
    Vaccine 32:4082-8. 2014
    ....
  24. ncbi How much cervical cancer in Australia is vaccine preventable? A meta-analysis
    Julia M L Brotherton
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, Locked Bag 4001, NSW 2145, Australia
    Vaccine 26:250-6. 2008
    ..7% of cervical cancers. This finding implies that Australia may have more to gain from the adoption of currently formulated HPV vaccines than other countries...
  25. ncbi The predicted impact of vaccination on human papillomavirus infections in Australia
    Megan A Smith
    Cancer Epidemiology Research Unit, The Cancer Council New South Wales, Woolloomooloo, New South Wales, Australia
    Int J Cancer 123:1854-63. 2008
    ..In conclusion, the current vaccination program is expected to result in a substantial and rapid reduction in the incidence of HPV16 in Australia...
  26. doi Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia
    Anthony T Newall
    School of Public Health, University of Sydney, New South Wales, Australia
    Clin Infect Dis 46:1647-55. 2008
    ..Seroepidemiology is a valuable tool, although the relationship between HPV infection and seropositivity is incomplete...
  27. ncbi Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in Australia
    Julia M L Brotherton
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia
    Pediatrics 115:e643-6. 2005
    ..This study aimed to determine the probability that an Australian infant who has died of SIDS was vaccinated in the days before death...
  28. doi Safety of human papillomavirus vaccines: a review
    Kristine K Macartney
    National Centre for Immunisation Research and Surveillance, Kids Research Institute, The Children s Hospital at Westmead, Cnr Hawkesbury Road and Hainsworth Street, Westmead Locked Bag 4001, Westmead, NSW 2145, Australia
    Drug Saf 36:393-412. 2013
    ..Whilst this reassuring safety profile affirms the positive risk benefit of vaccination, as HPV vaccine use expands into more diverse populations, including males, ongoing safety assessment using well-conducted studies is appropriate...